CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.
CHD8
CHD8-NDD
Autism
Dystonia
Exome sequencing
Movement disorders
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
05 Mar 2024
05 Mar 2024
Historique:
received:
08
01
2024
accepted:
19
02
2024
revised:
17
02
2024
medline:
5
3
2024
pubmed:
5
3
2024
entrez:
5
3
2024
Statut:
aheadofprint
Résumé
Heterozygous loss-of-function variants in CHD8 have been associated with a syndromic neurodevelopmental-disease spectrum, collectively referred to as CHD8-related neurodevelopmental disorders. Several different clinical manifestations, affecting neurodevelopmental and systemic domains, have been described, presenting with highly variable expressivity. Some expressions are well established and comprise autism spectrum disorders, psychomotor delay with cognitive impairment, postnatal overgrowth with macrocephaly, structural brain abnormalities, gastrointestinal disturbances, and behavioral and sleep-pattern problems. However, the complete phenotypic spectrum of CHD8-related disorders is still undefined. In 2021, our group described two singular female patients with CHD8-related neurodevelopmental disorder and striking dystonic manifestations, prompting the suggestion that dystonia should be considered a possible component of this condition. We describe three additional unrelated female individuals, each carrying a different CHD8 frameshift variant and whose clinical presentations were primarily characterized by young-onset dystonia. Their dystonic manifestations were remarkably heterogeneous and ranged from focal, exercise-dependent, apparently isolated forms to generalized permanent phenotypes accompanied by spasticity and tremor. Neurocognitive impairment and autistic behaviors, typical of CHD8-related disorders, were virtually absent or at the mild end of the spectrum. This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related neurodevelopmental disorders with potential female preponderance, raising new challenges and opportunities in the diagnosis and management of this condition. It also highlights the importance of in-depth neurologic phenotyping of patients carrying variants associated with neurodevelopmental disorders, as the connection between neurodevelopmental and movement disorders is proving closer than previously appreciated.
Sections du résumé
BACKGROUND
BACKGROUND
Heterozygous loss-of-function variants in CHD8 have been associated with a syndromic neurodevelopmental-disease spectrum, collectively referred to as CHD8-related neurodevelopmental disorders. Several different clinical manifestations, affecting neurodevelopmental and systemic domains, have been described, presenting with highly variable expressivity. Some expressions are well established and comprise autism spectrum disorders, psychomotor delay with cognitive impairment, postnatal overgrowth with macrocephaly, structural brain abnormalities, gastrointestinal disturbances, and behavioral and sleep-pattern problems. However, the complete phenotypic spectrum of CHD8-related disorders is still undefined. In 2021, our group described two singular female patients with CHD8-related neurodevelopmental disorder and striking dystonic manifestations, prompting the suggestion that dystonia should be considered a possible component of this condition.
CASE SERIES PRESENTATION
UNASSIGNED
We describe three additional unrelated female individuals, each carrying a different CHD8 frameshift variant and whose clinical presentations were primarily characterized by young-onset dystonia. Their dystonic manifestations were remarkably heterogeneous and ranged from focal, exercise-dependent, apparently isolated forms to generalized permanent phenotypes accompanied by spasticity and tremor. Neurocognitive impairment and autistic behaviors, typical of CHD8-related disorders, were virtually absent or at the mild end of the spectrum.
CONCLUSIONS
CONCLUSIONS
This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related neurodevelopmental disorders with potential female preponderance, raising new challenges and opportunities in the diagnosis and management of this condition. It also highlights the importance of in-depth neurologic phenotyping of patients carrying variants associated with neurodevelopmental disorders, as the connection between neurodevelopmental and movement disorders is proving closer than previously appreciated.
Identifiants
pubmed: 38441608
doi: 10.1007/s00415-024-12271-x
pii: 10.1007/s00415-024-12271-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Thompson BA, Tremblay V, Lin G, Bochar DA (2008) CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol 28(12):3894–3904
doi: 10.1128/MCB.00322-08
pubmed: 18378692
pmcid: 2423111
Weissberg O, Elliott E (2021) The Mechanisms of CHD8 in neurodevelopment and autism spectrum disorders. Genes 12(8):1133
doi: 10.3390/genes12081133
pubmed: 34440307
pmcid: 8393912
Shi X, Lu C, Corman A, Nikish A, Zhou Y, Platt RJ et al (2023) Heterozygous deletion of the autism-associated gene CHD8 impairs synaptic function through widespread changes in gene expression and chromatin compaction. Am J Hum Genet 110(10):1750–1768
doi: 10.1016/j.ajhg.2023.09.004
pubmed: 37802044
Ostrowski PJ, Zachariou A, Loveday C, Beleza-Meireles A, Bertoli M, Dean J et al (2019) The CHD8 overgrowth syndrome: a detailed evaluation of an emerging overgrowth phenotype in 27 patients. Am J Med Genet C Semin Med Genet 181(4):557–564
doi: 10.1002/ajmg.c.31749
pubmed: 31721432
Katayama Y, Nishiyama M, Shoji H, Ohkawa Y, Kawamura A, Sato T et al (2016) CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nature 537(7622):675–679
doi: 10.1038/nature19357
pubmed: 27602517
O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485(7397):246–250
doi: 10.1038/nature10989
pubmed: 22495309
pmcid: 3350576
Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O et al (2014) Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158(2):263–276
doi: 10.1016/j.cell.2014.06.017
pubmed: 24998929
pmcid: 4136921
Dingemans AJM, Truijen KMG, Van De Ven S, Bernier R, Bongers EMHF, Bouman A et al (2022) The phenotypic spectrum and genotype–phenotype correlations in 106 patients with variants in major autism gene CHD8. Transl Psychiatry 12(1):421
doi: 10.1038/s41398-022-02189-1
pubmed: 36182950
pmcid: 9526704
Guo H, Wang T, Wu H, Long M, Coe BP, Li H et al (2018) Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Mol Autism 9:64
doi: 10.1186/s13229-018-0247-z
pubmed: 30564305
pmcid: 6293633
Doummar D, Treven M, Qebibo L, Devos D, Ghoumid J, Ravelli C et al (2021) Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8. Ann Clin Transl Neurol 8(10):1986–1990
doi: 10.1002/acn3.51444
pubmed: 34415117
pmcid: 8528468
Poggio E, Barazzuol L, Salmaso A, Milani C, Deligiannopoulou A, Cazorla ÁG et al (2023) ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures. Genet Med 25(12):100971
doi: 10.1016/j.gim.2023.100971
pubmed: 37675773
Cif L, Demailly D, Lin JP, Barwick KE, Sa M, Abela L et al (2020) KMT2B -related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. Brain 143(11):3242–3261
doi: 10.1093/brain/awaa304
pubmed: 33150406
pmcid: 7719027
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
Bédard P, Panyakaew P, Cho HJ, Hallett M, Horovitz SG (2022) Multimodal imaging of essential tremor and dystonic tremor. NeuroImage Clin 36:103247
doi: 10.1016/j.nicl.2022.103247
pubmed: 36451353
pmcid: 9668651
Douzgou S, Liang HW, Metcalfe K, Somarathi S, Tischkowitz M, Mohamed W et al (2019) The clinical presentation caused by truncating CHD8 variants. Clin Genet 96(1):72–84
doi: 10.1111/cge.13554
pubmed: 31001818
Wigdor EM, Weiner DJ, Grove J, Fu JM, Thompson WK, Carey CE et al (2022) The female protective effect against autism spectrum disorder. Cell Genomics 2(6):100134
doi: 10.1016/j.xgen.2022.100134
pubmed: 36778135
pmcid: 9903803
Medina A, Nilles C, Martino D, Pelletier C, Pringsheim T (2022) The prevalence of idiopathic or inherited isolated Dystonia: a systematic review and meta-analysis. Mov Disord Clin Pract 9(7):860–868
doi: 10.1002/mdc3.13524
pubmed: 36247920
pmcid: 9547134
Peall KJ, Owen MJ, Hall J. Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes. Nat Rev Neurol. 2023 Nov 24;
Sugathan A, Biagioli M, Golzio C, Erdin S, Blumenthal I, Manavalan P et al (2014) CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A 111(42):E4468-4477
doi: 10.1073/pnas.1405266111
pubmed: 25294932
pmcid: 4210312
Kawamura A, Katayama Y, Kakegawa W, Ino D, Nishiyama M, Yuzaki M et al (2021) The autism-associated protein CHD8 is required for cerebellar development and motor function. Cell Rep 35(1):108932
doi: 10.1016/j.celrep.2021.108932
pubmed: 33826902